Improved glycemic control and reduced bodyweight with exenatide: A double-blind, randomized, phase 3 study in Japanese patients with suboptimally controlled type 2 diabetes over 24 weeks (Q33585633)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Improved glycemic control and reduced bodyweight with exenatide: A double-blind, randomized, phase 3 study in Japanese patients with suboptimally controlled type 2 diabetes over 24 weeks
scientific article

    Statements

    Improved glycemic control and reduced bodyweight with exenatide: A double-blind, randomized, phase 3 study in Japanese patients with suboptimally controlled type 2 diabetes over 24 weeks (English)
    Takashi Kadowaki
    Mitsuyoshi Namba
    Takeshi Imaoka
    Ayuko Yamamura
    Marilyn K Boardman
    Hideaki Sowa

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit